mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.09 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.09 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |